# Mitigating PM2.5-induced skin injury and aging: botanical strategies targeting redox and inflammatory pathways

**Authors:** Phetthinee Maunjumpon, Onusa Thamsermsang, Uraiwan Panich

PMC · DOI: 10.1080/13510002.2026.2629079 · Redox Report : Communications in Free Radical Research · 2026-02-19

## TL;DR

This paper reviews how PM2.5 harms the skin and explores plant-based solutions to reduce oxidative stress and inflammation.

## Contribution

The paper provides a critical review of botanical strategies targeting PM2.5-induced skin damage through redox and inflammatory pathways.

## Key findings

- PM2.5 causes oxidative stress and inflammation in skin cells, accelerating aging and impairing barrier function.
- Botanical compounds show promise in mitigating PM2.5 effects by modulating key signaling pathways like Nrf2 and NF-κB.
- Natural antioxidants and anti-inflammatory agents may protect skin health against environmental pollutants.

## Abstract

Exposure to fine particulate matter smaller than 2.5 μm in diameter (PM2.5) has emerged as a critical environmental factor contributing to skin injury. As the skin is the body’s primary barrier against the external environment, it is directly susceptible to PM2.5, which induces oxidative stress, inflammation, premature aging, and disruption of skin barrier function. Increasing evidence demonstrates that PM2.5 damages both epidermal keratinocytes and dermal fibroblasts, leading to cellular dysfunction through alterations in major signaling pathways, including the aryl hydrocarbon receptor (AhR), nuclear factor kappa B (NF-κB), activator protein 1 (AP-1), mitogen-activated protein kinase (MAPK), and nuclear factor erythroid 2–related factor 2 (Nrf2). These molecular perturbations accelerate skin aging and impair protective functions, highlighting the need for effective intervention strategies. Botanicals and their bioactive phytochemicals have attracted growing interest for their antioxidant and anti-inflammatory properties, which may counteract PM2.5-induced damage. By targeting redox imbalance and inflammatory signaling, natural compounds represent a promising approach for protecting skin health. This review highlights the role of PM2.5 in skin injury and critically examines botanical strategies that may mitigate PM2.5-induced skin damage and premature aging.

## Linked entities

- **Proteins:** AHR (aryl hydrocarbon receptor), NFKB1 (nuclear factor kappa B subunit 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), MAPK (mitogen activated kinase-like protein), GABPA (GA binding protein transcription factor subunit alpha)

## Full-text entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, NUFIP2 (nuclear FMR1 interacting protein 2) [NCBI Gene 57532] {aka 182-FIP, 82-FIP, FIP-82, NUFP2, PIG1}, GCLC (glutamate-cysteine ligase catalytic subunit) [NCBI Gene 2729] {aka CNSHA7, GCL, GCS, GLCL, GLCLC}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CUL3 (cullin 3) [NCBI Gene 8452] {aka CUL-3, NEDAUS, PHA2E}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, MAF (MAF bZIP transcription factor) [NCBI Gene 4094] {aka AYGRP, CCA4, CTRCT21, c-MAF}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, AQP3 (aquaporin 3 (Gill blood group)) [NCBI Gene 360] {aka AQP-3, GIL}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, NOX4 (NADPH oxidase 4) [NCBI Gene 50507] {aka KOX, KOX-1, RENOX}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, GSR (glutathione-disulfide reductase) [NCBI Gene 2936] {aka CNSHA10, GR, GSRD, HEL-75, HEL-S-122m}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, APAF1 (apoptotic peptidase activating factor 1) [NCBI Gene 317] {aka APAF-1, CED4}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, FLG (filaggrin) [NCBI Gene 2312] {aka ATOD2, FLG-1, FLG1}, IVL (involucrin) [NCBI Gene 3713], PTGER2 (prostaglandin E receptor 2) [NCBI Gene 5732] {aka COX-2, EP2}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, IL36G (interleukin 36 gamma) [NCBI Gene 56300] {aka IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, CHEK1 (checkpoint kinase 1) [NCBI Gene 1111] {aka CHK1, OZEMA21}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, BCL2L1 (BCL2 like 1) [NCBI Gene 598] {aka BCL-XL/S, BCL2L, BCLX, Bcl-X, PPP1R52}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** skin cancer (MESH:D012878), PM (MESH:D056784), pneumonia (MESH:D011014), carcinogenesis (MESH:D063646), stroke (MESH:D020521), COPD (MESH:D029424), psoriasis (MESH:D011565), metabolic disorders (MESH:D008659), neurodevelopmental deficits (MESH:D009461), fibrosis (MESH:D005355), inflammation (MESH:D007249), mitochondrial damage (MESH:D028361), skin injury (MESH:D000069836), impaired skin health (MESH:D012871), cancer (MESH:D009369), lung cancer (MESH:D008175), neurotoxicity (MESH:D020258), lung and skin epithelial injury (MESH:D055370), asthma (MESH:D001249), vitiligo (MESH:D014820), barrier (MESH:C536830), heart failure (MESH:D006333), atopic dermatitis (MESH:D003876), erythema (MESH:D004890), acne (MESH:D000152), chronic (MESH:D002908), tissue (MESH:D017695), inflammatory skin disorders (MESH:D012868), epithelial injury (MESH:D009375), hypertension (MESH:D006973), immune dysfunction (MESH:D007154), myocardial infarction (MESH:D009203), cytotoxicity (MESH:D064420)
- **Chemicals:** kaempferol (MESH:C006552), Salvianolic acid B (MESH:C076944), water (MESH:D014867), 3-BDB (MESH:C580724), Fucosterol (MESH:C015896), Terpenoids (MESH:D013729), PGE2 (MESH:D015232), squalene (MESH:D013185), iodoacetamide (MESH:D007460), eupafolin (MESH:C503624), catechin (MESH:D002392), ferulic acid (MESH:C004999), phenolic acids (MESH:C017616), iron (MESH:D007501), 4-HNE (MESH:C027576), copper (MESH:D003300), ascorbic acid (MESH:D001205), Resveratrol (MESH:D000077185), aldehydes (MESH:D000447), PAHs (MESH:D011084), hyaluronic acid (MESH:D006820), hydroxyl radical (MESH:D017665), squalene peroxide (MESH:C002821), 8-hydroxy-2'-deoxyguanosine (MESH:D000080242), cholesterol (MESH:D002784), xanthine (MESH:D019820), ethanol (MESH:D000431), isothiocyanate (MESH:C037152), BaP (MESH:D001564), quinones (MESH:D011809), GTE (MESH:C045651), Eckol (MESH:C060311), metal (MESH:D008670), hypoxanthine (MESH:D019271), gallic acid (MESH:D005707), aromatic amino acid (MESH:D024322), oxygen (MESH:D010100), quercetin (MESH:D011794), MDA (MESH:D015104), clionasterol (MESH:C025473), prostanoid (MESH:D011453), uric acid (MESH:D014527), polysaccharides (MESH:D011134), rutin (MESH:D012431), carbon (MESH:D002244), lipid peroxide (MESH:D008054), stilbenes (MESH:D013267), Pterostilbene (MESH:C107773), SFN (MESH:C016766), GSH (MESH:D005978), pentacyclic triterpenoid (MESH:D053978), ATP (MESH:D000255), polyphenol (MESH:D059808), ginsenoside Rb1 (MESH:C442759), sesquiterpene (MESH:D012717), sterols (MESH:D013261), OH (MESH:C031356), cysteine (MESH:D003545), lipid (MESH:D008055), LPS (MESH:D008070)
- **Species:** Salvia rosmarinus (rosemary, species) [taxon 39367], Saccharina japonica (species) [taxon 88149], Sargassum horneri (species) [taxon 74089], Styphnolobium japonicum (Japanese pagoda tree, species) [taxon 3897], Mus musculus (house mouse, species) [taxon 10090], Caulerpa racemosa (species) [taxon 76317], Salvia miltiorrhiza (Chinese salvia, species) [taxon 226208], Danio rerio (leopard danio, species) [taxon 7955], Phaeophyceae (brown algae, class) [taxon 2870], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168), SZ95 — Homo sapiens (Human), Transformed cell line (CVCL_9803), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), CCD-966SK — Homo sapiens (Human), Finite cell line (CVCL_U267), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927407/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927407/full.md

## References

162 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927407/full.md

---
Source: https://tomesphere.com/paper/PMC12927407